EN DE
Watch Celanese Corporation for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Celanese Corporation (CE) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Celanese Corporation stock $60.28, price $46.49, upside +29.7%, quality 42 out of 100. Rating: undervalued. Calculated from audited financials with 7 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials US

CC Celanese Corporation logo Some data Nov 7, 2026

Celanese Corporation

CE · US
Speculative

The stock costs 23% less than our calculation considers fair.

Fair value $60.28 · Undervalued
Generates free cash flow
0.3% dividend yield · Cash covered
Positive coverage
Even on cautious assumptions the value is 30% above the price ($60.28).
Quality 42/100
Mixed Growth (revenue 5y +11.0 %/yr in USD)
Insiders bought $230,066 (6M)
Some data
Loss-making · -12.0% net margin (TTM)
High debt
Trails peers (4/13)
Narrow moat 20/100 · thin data
⟳ Cyclical

Risks from the AI analysis

🚩Chinese overcapacity squeezes acetyl and polymer prices
Watch Celanese Corporation for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$168.57 $35.47 Fair Value $60.28 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

60‑month range $35.47 – $168.57 · fair‑value band $60.28 – $140.58 · the $46.49 price screens below the $60.28 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 7, 2026.

Follow Celanese in your weekly email

Every Wednesday you see whether Celanese is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments.

Show moreShow less

The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular weight polyethylene, and thermoplastic elastomers, polyesters, and vulcanizates for use in appliance, automotive, construction, consumer apparel, consumer electronics, electrical, energy storage, filtration equipment, industrial, medical, and telecommunication applications.

It also provides acetic acid and anhydride, acetate flakes and tows, butyl acetates, emulsion polymers, ethyl acetates, ethylene vinyl acetate resins and compounds, formaldehydes, redispersible powders, and vinyl acetate monomers for use in adhesives, automotive parts, coatings, consumer goods, external thermal insulation composite systems, films, filtration, flexible packaging, food and beverage, food packaging, inks, lamination, lubricants, paints, paper finishing, pharmaceuticals, plasticizers, plasters and renders, solvents, textiles, and tiling applications.

The company offers its products under the Amcel, AOPlus, Ateva, Avicor, Celanese, Celanex, Celanyl, Celcon, Celstran, Celvolit, Clarifoil, Crastin, Dur-O-Set, Dytron, ECOMID, EcoVAE, Elotex, Factor, Flexbond, Forprene, FRIANYL, Fortron, Geolast, GHR, GUR, Hostaform, Hytrel, Laprene, Melinex, MetaLX, Mowilith, MT, Mylar, NILAMID, Nylfor, OmniLon, Pibifor, Pibiter, Polifor, Resyn, Rynite, Santoprene, SlideX, Sofprene, Sofpur, Talcoprene, Tarnoform, Tecnoprene, TufCOR, Tynex, Vamac, VAntage, Vectra, Vinac, Vinamul, VitalDose, Zenite, and Zytel brands.

It sells its products directly to customers and through distributors; and original equipment manufacturers and suppliers. Celanese Corporation was founded in 1912 and is headquartered in Irving, Texas.

Stock analysis

Celanese Corporation (CE) currently trades at $46.49, while our model-based Fair Value estimate is $60.28, implying the stock looks roughly 23% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $65.91 per share, and 2 of the 6 models we run sit above the $46.49 price.

Bear case: the DCF Models group reads lowest at $36.89, and 4 of the 6 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $60.28 (bear) to $140.58 (bull), the price of $46.49 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Basic Materials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Celanese Corporation reported revenue of $9.5B in FY2025 versus $8.5B in FY2021, a compound +2.8%/yr. Reported net income was −$1.2B in FY2025.

Key figures

Market cap $5.1B Mid · P/E ex one-offs 11.7 · P/S ratio 0.57 · EPS (TTM) $−10.60 · Dividend yield 0.3% · Net margin −12.0% · Return on equity −22.3% · Return on assets (EBIT) 5.7% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 20 out of 100 (low confidence).

What moves the price

The share trades about 33% below its 52-week high and 31% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −25% fair-value upside, at 30%, CE screens cheaper than that median.

Fair Value models

Bear $60.28 Fair Value $60.28 Bull $140.58
Price $46.49 · Upside +29.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $42.30 $98.41 $176.97 76
Growth DCF $46.60 $99.43 $170.57 75
5Y Revenue Exit n/a $30.14 $70.29 69
All 7 models by family
DCF Models
FCF DCF $42.30 $98.41 $176.97 76
5Y Revenue Exit n/a $30.14 $70.29 69
10Y Revenue Exit $10.72 $43.64 $82.02 62
10Y EBITDA Exit n/a $0.8000 >$3.20 65
Multiples
EV/Revenue n/a n/a $17.31 50
Growth DCF
Growth DCF $46.60 $99.43 $170.57 75
Rev-Margin DCF n/a $32.39 $70.88 69

The fair value above starts from this blend and is adjusted for a cyclical trough year.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 42/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 8
How much profit the company makes from its sales and capital
Quality Growth 30
Are margins and returns getting better?
Cashflow 51
Do the profits arrive as real cash?
Financial strength 13
Debt, balance sheet and risk of trouble
Investment 97
Does it invest with discipline instead of growing at any price?
Low Volatility 52
How calm the share price moves, does not count
Price momentum 43
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 48
Distance to the 52-week high, does not count
New shares 77
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, 3 officers or directors bought shares worth $230,066, most recently on Aug 14, 2026. Buying cluster

  • BuyChuck KyrishSVP & CFO2× since Dec 9, 2025: 7,300 shares, avg. $42.45$309,851Aug 14, 2026
  • BuyAshley B DuffieSVP & GC600 shares at $45.60$27,360Aug 11, 2026
  • BuyMark Christopher MurraySVP - Acetyls2,153 shares at $45.52$98,005Aug 11, 2026
  • BuyScott A RichardsonCEO & President, Director3,800 shares at $41.59$158,042Dec 10, 2025

Plus 10 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 54/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−7.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.0%
Start year 2020 (pandemic). Over 10 years: +5.3% a year
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
13.2% (2019) → −6.8% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes about as much growth as the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+8.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+1.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +5.7% a year for the price and −1.0% for the forecasts.
Forecast 2026 (sales)+3.6%
Forecast 2027 (sales)+0.6%
Projected 2028 (sales)+0.8%
Projected 2029 (sales)+0.9%
Projected 2030 (sales)+1.1%

Watch CE, get fair value alerts →

Recent news

News mood ⓘNews mood, the average tone of recent news (98 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Positive
Recent news coverage is more positive than average.
Note from the team Oct 11, 2026
AI conclusion: Targeted price increases in polyamides offer a focused response in engineered materials, yet sustained net losses and elevated debt underscore limited evidence of durable advantage.
Main risk: Chinese producers expanding capacity in acetyls and engineered materials could undercut prices on standard grades and squeeze margins in Celanese's acetyl chain and polyamide businesses.
Bull case: By focusing on specialty polymers, sustainability solutions such as carbon-capture POM grades and growth in electronics for AI data centers, Celanese could strengthen its position in higher-margin applications and reduce reliance on standard products.
Bear case: Ongoing additions of low-cost capacity by Chinese competitors might keep pricing pressure elevated in acetyls and standard engineered materials, leading to sustained lower utilization rates and slower recovery in the core businesses.
Celanese is lifting prices on certain polyamide products in the Americas from mid-October to offset higher costs and shifting market conditions. The third-quarter results next month and the December investor event will show whether these moves can protect margins in engineered materials while end markets such as automotive stay under pressure. Will pricing gains more than offset any volume softness?
Join the discussion →

Compare Celanese Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 339 stocks

Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 42 · Bottom 25%
Fair Value upside +29.7% · Top 25%
Profitability
Return on assets −5.4% · Bottom 25%
Net margin (12 months) −12.0% · Bottom 25%
Operating margin (12 months) 11.1% · Above median
Growth and dividend
Revenue growth (quarter YoY) 8.7% · Below median
Dividend yield (12 months) 0.3% · Bottom 25%
Balance sheet
Debt / equity 2.81× · Highest 25%

Valuation Multiplesvs Chemicals median · lower = cheaper

P/B 1.27× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.53× · Cheapest 25%
Price / free cash flow (fiscal year) 6.4× · Cheapest 25%
EV/EBITDA 9.1× · Pricier than median
PEG 1.74× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)73 · sector 9
FUTURE (revenue growth)44 · sector 67
PAST (return on equity)0 · sector 24
HEALTH (low debt)0 · sector 94
DIVIDEND (yield)5 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
LG Chem, Ltd 051910 220,000 KRW 587,755 KRW +167% vs CE
Dow Inc DOW $31.40 $41.88 +33% vs CE
Hengli Petrochemical Co 600346 ¥16.35 ¥19.26 +18% vs CE
Ningxia Baofeng Energy Group 600989 ¥21.33 ¥22.31 +5% vs CE
Saudi Basic Industries Corporation 2010 48.30 SAR 36.26 SAR −25% vs CE
BASF SE BAS €53.85 €38.46 −29% vs CE
Zhejiang Juhua Co 600160 ¥32.13 ¥19.31 −40% vs CE
Formosa Chemicals & Fibre Corporation 1326 68.90 TWD 35.56 TWD −48% vs CE
Rongsheng Petrochemical Co 002493 ¥11.77 ¥3.45 −71% vs CE
Zangge Mining Company 000408 ¥66.41 ¥17.47 −74% vs CE

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Celanese Corporation: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Celanese Corporation Fair Value". https://www.fairvalue-calculator.com/stock/CE

Frequently asked questions

Is Celanese Corporation (CE) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of $60.28 versus a price of $46.49, about +30% upside (undervalued).
What is the fair value of CE?
Our model-based fair value for Celanese Corporation is $60.28 (as of Nov 7, 2026), built from audited fundamentals. The current price: $46.49.
What is the quality score of CE?
Celanese Corporation has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Celanese Corporation (CE)?
Our model-based price target is the fair value of $60.28 (as of Nov 7, 2026) from 7 valuation models. Cautious scenario $60.28, optimistic scenario $140.58. It is a calculation from audited fundamentals, not an analyst target.
What is the Celanese Corporation stock forecast for 2026?
Our models put fair value at $60.28, about +30% upside versus a price of $46.49 (undervalued). Cautious scenario $60.28, optimistic scenario $140.58. The calculation is refreshed regularly with new filings.
What is the revenue of Celanese Corporation (CE)?
Celanese Corporation reported trailing-twelve-month revenue of about $9.7B (latest available figure, as of Nov 7, 2026).
Does Celanese Corporation pay a dividend?
Celanese Corporation currently shows a dividend yield of 0.26% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Celanese Corporation (CE) and when is the ex-dividend date?
Celanese Corporation pays a dividend of $0.12 per share a year, a dividend yield of 0.3%. The last ex-dividend date was Oct 27, 2026. A dividend has been paid every year since at least 2005. Free cash flow covers the dividend 60.97 times. Our assessment: Cash covered. The dividend is fully funded by free cash flow. The payout ratio on earnings is not available for this company.
What growth is priced into Celanese Corporation (CE)?
For today's price to be fair in a discounted-cash-flow model, Celanese Corporation would have to grow free cash flow by +8.2 % per year for five years (discount rate 9.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +11.0 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of CE use?
Our models discount Celanese Corporation at 9.0 %: a base by market capitalisation (mid), damped by beta 0.71, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Celanese Corporation that is +8.2 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.0 %) and the same formula as our fair value.
How much growth has Celanese Corporation (CE) delivered so far?
Over the past 5 years revenue at Celanese Corporation grew +11.0 % a year. The price currently implies free-cash-flow growth of +8.2 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Celanese Corporation (CE) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Celanese Corporation (+8.2 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Celanese Corporation (CE)?
The free-cash-flow yield on the price is 15.67 %: that much free cash flow Celanese Corporation produces per unit of market value. When it exceeds the discount rate of our models (9.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Celanese Corporation (CE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Celanese Corporation it is $60.28 per share (as of Nov 7, 2026), against a price of $46.49. It is the blended result of 7 valuation models in 3 families (DCF Models, Multiples, Growth DCF).
Is Celanese Corporation stock overvalued or undervalued in 2026?
As of Nov 7, 2026, CE trades below its calculated fair value: price $46.49, fair value $60.28, a gap of about +30% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CE?
No. The price is what the market pays today ($46.49); the fair value is what the company's own numbers justify ($60.28). For Celanese Corporation the two are $13.79 per share apart. That gap is exactly why we show both numbers side by side.
How much is Celanese Corporation worth?
The market values Celanese Corporation at about $5.1B (market capitalisation, as of Nov 7, 2026). Per share that is $46.49; our models calculate a fair value of $60.28 per share.
What do the bullish and bearish scenarios say about CE?
Our models span a range for Celanese Corporation: cautious scenario $60.28, base $60.28, optimistic $140.58 per share (as of Nov 7, 2026, price $46.49). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of CE?
The PEG ratio of Celanese Corporation is 1.74 (P/E divided by earnings growth, as of Nov 7, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Celanese Corporation (CE)?
Balance-sheet figures for Celanese Corporation (as of Nov 7, 2026): return on equity −22.3%, debt of 2.81 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is CE from its 52-week high?
Celanese Corporation trades at $46.49, about 33% below its 52-week high of $69.19 and 31% above the low of $35.47 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $60.28 is for.
Which stocks are comparable to Celanese Corporation?
From the same area (Basic Materials) we also value BASF SE, Saudi Basic Industries Corporation, Dow Inc, Ningxia Baofeng Energy Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Celanese Corporation stock attractive at the current price?
The data as of Nov 7, 2026: price $46.49, calculated fair value $60.28 (+30%), Quality Score 42/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CE calculated?
We run Celanese Corporation through 7 models from 3 families: DCF Models, Multiples, Growth DCF. Every model gets the same audited fundamentals; the fair value of $60.28 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Celanese Corporation currently trades 23% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Celanese Corporation (CE)?
The closing price on Nov 6, 2026 was $46.49. Our model-based fair value is $60.28, about +30% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Celanese Corporation right now?
The price is below even our cautious bear case ($60.28). The market is more pessimistic than our downside scenario. A fairly wide model range ($60.28 to $140.58) leaves room in how you read the outcome.

Key figures of Celanese Corporation

How large is the market capitalisation of Celanese Corporation (CE)?
The market capitalisation of Celanese Corporation is $5.1B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of Celanese Corporation (CE) excluding one-off items?
Excluding one-off items, the price-to-earnings ratio of Celanese Corporation is 11.7 (fiscal year 2025, the reported result was a loss, median at FY-end 10.1 (9 FY)).
What is the P/S ratio of Celanese Corporation (CE)?
The price-to-sales ratio of Celanese Corporation is 0.57 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Celanese Corporation (CE)?
Earnings per share at Celanese Corporation are $−10.60. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Celanese Corporation (CE)?
The dividend yield of Celanese Corporation is 0.3%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Celanese Corporation (CE)?
The net margin of Celanese Corporation is −12.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Celanese Corporation (CE)?
The return on equity (ROE) of Celanese Corporation is −22.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Celanese Corporation (CE)?
On an EBIT basis the return on assets of Celanese Corporation is 5.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Celanese Corporation (CE)?
The operating margin of Celanese Corporation is 11.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Celanese Corporation (CE)?
Revenue at Celanese Corporation is growing +8.7% versus a year earlier (3y avg −0.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Celanese Corporation (CE)?
Earnings per share at Celanese Corporation are growing −37.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Celanese Corporation (CE) carry?
The net debt of Celanese Corporation is $11.7B (fiscal year 2025, ≈ 14.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Celanese Corporation in the live analysis

One click puts Celanese Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.